Eli Lilly is the clear leader in the burgeoning weight loss market. Its lineup and pipeline put it well ahead of even its ...

People covered by Obamacare and Medicaid may see health care costs rise, but for people on Medicare, Biden-era negotiated ...

While the drugs have become spectacularly popular, their high prices, along with spotty insurance coverage, have left them ...

Asian shares are mixed in thin holiday trading, with most markets in the region and elsewhere closed for Christmas ...

Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. Trading was extremely light ...

About 14% of adults in Philadelphia have diabetes, one of the highest rates in the country, the city said, and Black and ...

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 ...

Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. The Standard & Poor’s 500 index rose 22.26 points, or 0.3%, to 6,932.05. The Dow Jones industrial ...

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 for weight management ...

The era of "oral obesity medications" has officially begun as Danish pharmaceutical company Novo Nordisk’s obesity treatment received U.S. Food and Drug Administration (FDA) approval in pill form.

A $1,000 investment will buy you nearly 20 shares of Bristol Myers Squibb (NYSE: BMY) and about 10 shares of Medtronic (NYSE: ...

NEW YORK -- Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. The S&P 500 ...